These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8696956)

  • 1. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1.
    Jong MC; Dahlmans VE; van Gorp PJ; Breuer ML; Mol MJ; van der Zee A; Frants RR; Hofker MH; Havekes LM
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):934-40. PubMed ID: 8696956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice.
    Jong MC; van Ree JH; Dahlmans VE; Frants RR; Hofker MH; Havekes LM
    Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):445-50. PubMed ID: 9020879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ; van 't Hof HB; Mol MJ; van der Boom H; van der Zee A; Frants RR; Hofker MH; Havekes LM
    J Clin Invest; 1996 Mar; 97(5):1184-92. PubMed ID: 8636429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia.
    van den Maagdenberg AM; Hofker MH; Krimpenfort PJ; de Bruijn I; van Vlijmen B; van der Boom H; Havekes LM; Frants RR
    J Biol Chem; 1993 May; 268(14):10540-5. PubMed ID: 7683682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice.
    Duivenvoorden I; Voshol PJ; Rensen PC; van Duyvenvoorde W; Romijn JA; Emeis JJ; Havekes LM; Nieuwenhuizen WF
    Am J Clin Nutr; 2006 Aug; 84(2):312-21. PubMed ID: 16895877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice.
    van Vlijmen BJ; van Dijk KW; van't Hof HB; van Gorp PJ; van der Zee A; van der Boom H; Breuer ML; Hofker MH; Havekes LM
    J Biol Chem; 1996 Nov; 271(48):30595-602. PubMed ID: 8940032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of transgenic mice in lipoprotein metabolism and atherosclerosis research.
    Havekes LM; van Vlijmen BJ; Jong MC; van Dijk KW; Hofker MH
    Prostaglandins Leukot Essent Fatty Acids; 1997 Oct; 57(4-5):463-6. PubMed ID: 9430397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis.
    Huang Y; Ji ZS; Brecht WJ; Rall SC; Taylor JM; Mahley RW
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2952-9. PubMed ID: 10591675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice.
    van Vlijmen BJ; Mensink RP; van 't Hof HB; Offermans RF; Hofker MH; Havekes LM
    J Lipid Res; 1998 Jun; 39(6):1181-8. PubMed ID: 9643349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice.
    Mensenkamp AR; van Luyn MJ; van Goor H; Bloks V; Apostel F; Greeve J; Hofker MH; Jong MC; van Vlijmen BJ; Havekes LM; Kuipers F
    J Hepatol; 2000 Aug; 33(2):189-98. PubMed ID: 10952236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E2 (Lys146-->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides.
    de Beer F; van Dijk KW; Jong MC; van Vark LC; van der Zee A; Hofker MH; Fallaux FJ; Hoeben RC; Smelt AH; Havekes LM
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1800-6. PubMed ID: 10894820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased response to cholesterol feeding in apolipoprotein C1-deficient mice.
    van Ree JH; Hofker MH; van den Broek WJ; van Deursen JM; van der Boom H; Frants RR; Wieringa B; Havekes LM
    Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):905-11. PubMed ID: 7848292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
    Mensenkamp AR; Jong MC; van Goor H; van Luyn MJ; Bloks V; Havinga R; Voshol PJ; Hofker MH; van Dijk KW; Havekes LM; Kuipers F
    J Biol Chem; 1999 Dec; 274(50):35711-8. PubMed ID: 10585451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL.
    Berbée JF; van der Hoogt CC; Sundararaman D; Havekes LM; Rensen PC
    J Lipid Res; 2005 Feb; 46(2):297-306. PubMed ID: 15576844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
    Koopmans SJ; Jong MC; Que I; Dahlmans VE; Pijl H; Radder JK; Frölich M; Havekes LM
    Diabetologia; 2001 Apr; 44(4):437-43. PubMed ID: 11357474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL.
    Westerterp M; de Haan W; Berbée JF; Havekes LM; Rensen PC
    J Lipid Res; 2006 Jun; 47(6):1203-11. PubMed ID: 16537968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice.
    Tsukamoto K; Maugeais C; Glick JM; Rader DJ
    J Lipid Res; 2000 Feb; 41(2):253-9. PubMed ID: 10681409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia.
    Huang Y; Liu XQ; Rall SC; Taylor JM; von Eckardstein A; Assmann G; Mahley RW
    J Biol Chem; 1998 Oct; 273(41):26388-93. PubMed ID: 9756870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.